NKGen Biotech, Inc.
NKGN
$0.1275
$0.00151.19%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 141.01% | -198.92% | 83.99% | -1.29% | -322.69% |
| Total Depreciation and Amortization | 1.84% | 0.00% | 8.67% | 0.00% | 0.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -229.38% | 869.35% | -105.02% | -8.70% | 1,032.96% |
| Change in Net Operating Assets | 1,239.02% | -94.59% | 60.55% | 43.86% | 351.28% |
| Cash from Operations | 35.07% | -48.71% | 41.86% | -52.00% | 17.45% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.33% | -- | -- | -- | 100.00% |
| Cash from Investing | -13.33% | -142.86% | 294.44% | -- | 100.00% |
| Total Debt Issued | -66.93% | 462.55% | 2,356.67% | -99.53% | 58.76% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -99.94% | 20,737.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 227.94% | -188.16% | 261.96% | 32.82% | -26.59% |
| Cash from Financing | -36.95% | 51.21% | 322.24% | -114.87% | 93.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -304.44% | 462.50% | 100.09% | -215.81% | 944.75% |